Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
10/19/2005 | CN1223372C Capsule for treating gastritis and gastric ulcer its preparing method |
10/19/2005 | CN1223366C Hemostat and its usage |
10/19/2005 | CN1223361C Medicine for treating hepatitis B virus |
10/19/2005 | CN1223360C Chinese medicine for treating qi obstruction in chest |
10/19/2005 | CN1223359C Chinese herbal medicine wine for tonifying kidney and promoting blood circulation |
10/19/2005 | CN1223358C Chinese medicinal herbs preparation for treating nephritic syndrome and its preparing method |
10/19/2005 | CN1223357C Chinese medicine for treating gastrosis |
10/19/2005 | CN1223356C Medicine for treating lithiasis |
10/19/2005 | CN1223354C Chinese proprietary medicine for treating colitis |
10/19/2005 | CN1223353C Yin-nourishing and heat-clearing, mental anxiety easing preparation |
10/18/2005 | US6956144 Mixture with flow control agents; antiulcer agents |
10/18/2005 | US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses |
10/18/2005 | US6956026 Use of exendins for the reduction of food intake |
10/18/2005 | US6955802 Homeodomain protein code specifying progenitor cell identify and neuronal fate in the ventral neural tube |
10/18/2005 | US6955682 Wound closure system and methods |
10/18/2005 | CA2333160C Additives for crustacean or fish feeds and feeds |
10/18/2005 | CA2283280C Reovirus for the treatment of neoplasia |
10/18/2005 | CA2221605C Methods and devices for the removal of psoralens from blood products |
10/15/2005 | CA2464550A1 Embryonic development following icsi with human air dried sperms in oocytes |
10/13/2005 | WO2005095656A1 Lactic acid bacteria strains exhibiting probiotic properties and compositions comprising the same |
10/13/2005 | WO2005095613A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF |
10/13/2005 | WO2005095598A1 Cancer antigen peptide originating in wt1 |
10/13/2005 | WO2005095590A2 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations |
10/13/2005 | WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same |
10/13/2005 | WO2005095585A1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
10/13/2005 | WO2005095581A1 Cell carrier and cell carrier containment devices containing regenerative cells |
10/13/2005 | WO2005095579A1 Process |
10/13/2005 | WO2005094914A1 Preparation of a nucleated cell and/or platelet concentrate from a physiological solution |
10/13/2005 | WO2005094911A2 Composite materials |
10/13/2005 | WO2005094900A1 Preventive and/or remedy for cancer |
10/13/2005 | WO2005094888A1 Damaged tissue therapeutic agent and therapeutic method |
10/13/2005 | WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
10/13/2005 | WO2005094878A1 Composition having antitumor effect |
10/13/2005 | WO2005094867A1 Anticancer activity enhancer of viral therapy and method of cancer prevention or treatment |
10/13/2005 | WO2005094853A1 Propolis extract and method for extracting the same |
10/13/2005 | WO2005094852A2 Sperm suspensions for use in insemination |
10/13/2005 | WO2005094851A1 Water-soluble fraction extracted from animal organ, method of producing the same, reverse transcription inhibitor, reverse transcriptase inhibitor, viral growth inhibitor and medicinal compositions |
10/13/2005 | WO2005094850A1 Antibacterial composition |
10/13/2005 | WO2005094849A1 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
10/13/2005 | WO2005094848A1 Agent for preventing or suppressing hepatopathy and functional food for preventing or suppressing hepatopathy |
10/13/2005 | WO2005094847A1 Process for producing bone marrow cell inducer and production apparatus therefor |
10/13/2005 | WO2005094846A1 Remedy for prion disease and method of producing the same |
10/13/2005 | WO2005094162A2 Culture and use of cells that secrete liver secretory factors |
10/13/2005 | WO2005079471A3 Cytotoxin compound and method of isolation |
10/13/2005 | WO2005070011A3 Improved modalities for the treatment of degenerative diseases of the retina |
10/13/2005 | WO2005063969A3 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
10/13/2005 | WO2003068954A8 Microorganism for genetic therapeutic treatment of proliferative diseases |
10/13/2005 | WO2003031643A3 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
10/13/2005 | US20050228333 Method of stimulating blood-derived components using no added thrombin or other agonist |
10/13/2005 | US20050228170 B7-like molecules and uses thereof |
10/13/2005 | US20050227937 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
10/13/2005 | US20050227924 Peyer's patch and/or M-cell targeting ligands |
10/13/2005 | US20050227912 Hemoglobin composed 2 polypeptides, each having a normal human hemoglobin alpha chain amino acid sequence, and 2 polypeptides, each having a normal normal bovine hemoglobin beta chain amino acid sequence; at least one polypeptide has a mutation that introduces a polymerization site; nucleic acid |
10/13/2005 | US20050227910 Local regional chemotherapy and radiotherapy using in situ hydrogel |
10/13/2005 | US20050227354 Using fibronectin nutrient broth to propagate cytotoxic lymphocyte with enhanced interleukin-2 receptor expression profiles; immunotherapy; antitumor agents |
10/13/2005 | US20050227353 Methods of inducing differentiation of stem cells |
10/13/2005 | US20050226857 T cell therapy for the treatment of cachexia and chronic diseases |
10/13/2005 | US20050226855 Transformation of pluripotential stem cells for tissue repain, replacement in organs such as heart, brain, liver, kidney or pancreas; supplying cells using catheters |
10/13/2005 | US20050226854 treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof by transplanting into the subject tissue derived from a human or porcine kidney or liver, the kidney or liver being at a selected gestational stage |
10/13/2005 | US20050226851 Lysin-deficient bacteriophages having reduced immunogenicity |
10/13/2005 | US20050226850 Treatment of non-neuronal cancer using HSV-1 variants |
10/13/2005 | US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses |
10/13/2005 | US20050226830 Nano pearl cream |
10/13/2005 | DE10031851B4 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension Photodynamic treatment and UV-B irradiation of a platelet suspension |
10/13/2005 | CA2566374A1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
10/13/2005 | CA2563103A1 Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer |
10/13/2005 | CA2562947A1 Antibacterial composition comprising cheese and low ph |
10/13/2005 | CA2561725A1 Culture and use of cells that secrete liver secretory factors |
10/13/2005 | CA2561661A1 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations |
10/13/2005 | CA2561519A1 Sperm dispersions for use in insemination |
10/13/2005 | CA2561149A1 Process using pulsed electromagnetic field treatment to produce a composition comprising dried microorganisms |
10/13/2005 | CA2560052A1 Cell carrier and cell carrier containment devices containing regenerative cells |
10/13/2005 | CA2559865A1 Preparation of a cell concentrate from a physiological solution |
10/12/2005 | EP1584622A2 Compounds for the photodecontamination of pathogens in blood |
10/12/2005 | EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
10/12/2005 | EP1583423A2 Intradermal cellular delivery using narrow gauge micro-cannula |
10/12/2005 | EP1583422A2 Cell-based therapies for ischemia |
10/12/2005 | EP1583419A1 Method of prolonging the life-span of living cells using nadh, nadph and adp-ribose |
10/12/2005 | EP1515737B1 An ayurvedic nutritional preparation |
10/12/2005 | EP1334135B1 Resin based on polystyrene functionalised by methyl ester groups of l-tyrosine and their uses |
10/12/2005 | EP1305410B1 Insulin producing cell-line obtained by electrofusion |
10/12/2005 | EP1294918B1 Replication deficient adenoviral tnf vector |
10/12/2005 | EP1274721B1 Haemostatically active preparation containing vwf and method for the production thereof |
10/12/2005 | EP1162890B1 A method of preventing parturient hypocalcemia in animals and compositions used therein |
10/12/2005 | EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
10/12/2005 | EP0669979B1 C-c ckr-1, c-c chemokine receptor |
10/12/2005 | EP0556345B2 Retroviral vectors useful for gene therapy |
10/12/2005 | CN2732244Y Live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus ceresu composite dispersible agent |
10/12/2005 | CN2732243Y Live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus ceresu composite capsule |
10/12/2005 | CN1681918A Transplant acceptance inducing cells of monocytic origin and their preparation and use |
10/12/2005 | CN1681522A Megasphaera elsdenii strain and its uses |
10/12/2005 | CN1681521A Method for purifying a biological composition |
10/12/2005 | CN1680549A Dendritic cell obtained by antigen pulsing |
10/12/2005 | CN1680546A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
10/12/2005 | CN1680545A Acid and choline-resistant separated strain of lactobacoillus with ability of reducing and assimilating cholesterol |
10/12/2005 | CN1680544A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
10/12/2005 | CN1680543A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
10/12/2005 | CN1680542A Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
10/12/2005 | CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
10/12/2005 | CN1680442A Truncated VEGF-related proteins |